Endoscopist's Judgment Is as Useful as Risk Scores for Predicting Outcome in Peptic Ulcer Bleeding: A Multicenter

Enric Brullet1,2,3, Pilar Garcia-Iglesias1,2,3, Xavier Calvet1,2,3

  • 1Hospital de Sabadell, Corporació Sanitària Universitària Parc Taulí, 08208 Sabadell, Spain.

Insights

Endoscopist judgment in peptic ulcer bleeding (PUB) showed accuracy similar or superior to current risk scores for predicting rebleeding and mortality. More precise prognostic scales are needed for better patient risk stratification.

Area of Science:

  • Gastroenterology
  • Clinical Medicine
  • Medical Diagnostics

Background:

  • Guidelines advocate prognostic scales for risk stratification in non-variceal upper gastrointestinal bleeding.
  • The comparative accuracy of risk scores versus clinical judgment remains uncertain.
  • Peptic ulcer bleeding (PUB) management benefits from accurate risk assessment.

Purpose of the Study:

  • To compare the diagnostic accuracy of endoscopist judgment against established risk scores (Rockall, Glasgow-Blatchford, Baylor, Cedars-Sinai) for predicting outcomes in peptic ulcer bleeding.
  • To evaluate the predictive performance for rebleeding and mortality.
  • To assess the utility of current risk stratification tools in PUB management.

Main Methods:

  • Prospective study of 401 patients with peptic ulcer bleeding (PUB) from February 2006 to April 2010.
  • Endoscopist's subjective risk assessment for rebleeding and mortality recorded immediately post-endoscopy.
  • Independent calculation of Rockall, Glasgow-Blatchford, Baylor, and Cedars-Sinai scores.
  • Analysis using receiver-operating-characteristics (ROC) curves, sensitivity, specificity, and predictive values.

Main Results:

  • Endoscopist's clinical judgment demonstrated areas under the ROC curve for rebleeding (0.67-0.75) and mortality (0.84-0.9).
  • These values were comparable or superior to those of the studied risk scores.
  • The findings held true for both the entire patient cohort and those undergoing endoscopic therapy.

Conclusions:

  • Current risk scores for predicting rebleeding and mortality in peptic ulcer bleeding patients have moderate accuracy.
  • Endoscopist's clinical judgment was not outperformed by existing risk scoring systems.
  • Development of more precise prognostic scales is necessary for improved risk stratification in PUB.

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
471
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
361
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
681
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
736
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.8K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
984